Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_provenance.
- NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_assertion description "[These analyses revealed that 5 genes, i.e., AMOG (ATP1B2, 17p13.1), APOD (3q26.2-qter), DMXL1 (5q23.1) DRR1 (TU3A, 3p14.2) and PSD3 (KIAA09428/HCA67/EFA6R, 8p22), were expressed at significantly lower levels in secondary glioblastomas as compared to diffuse astrocytomas of WHO grade II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_provenance.
- NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_assertion evidence source_evidence_literature NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_provenance.
- NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_assertion SIO_000772 16865689 NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_provenance.
- NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_assertion wasDerivedFrom befree-2016 NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_provenance.
- NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_assertion wasGeneratedBy ECO_0000203 NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_provenance.
- befree-2016 importedOn "2016-02-19" NP561270.RAWst8-KLnwcd16a0DH664l46qIZ6oxqeFKAbQES1VEM0130_provenance.